SAMHD1 limits HIV-1 infection in non-dividing myeloid cells by decreasing intracellular dNTP pools. HIV-1 restriction by SAMHD1 in these cells likely prevents activation of antiviral immune responses and modulates viral pathogenesis, thus highlighting a critical role of SAMHD1 in HIV-1 physiopathology. Here, we explored the function of SAMHD1 in regulating cell proliferation, cell cycle progression and apoptosis in monocytic THP-1 cells. Using the CRISPR/Cas9 technology, we generated THP-1 cells with stable SAMHD1 knockout. We found that silencing of SAMHD1 in cycling cells stimulates cell proliferation, redistributes cell cycle population in the G 1 /G 0 phase and reduces apoptosis. These alterations correlated with increased dNTP levels and more efficient HIV-1 infection in dividing SAMHD1 knockout cells relative to control. Our results suggest that SAMHD1, through its dNTPase activity, affects cell proliferation, cell cycle distribution and apoptosis, and emphasize a key role of SAMHD1 in the interplay between cell cycle regulation and HIV-1 infection.
Introduction
SAM domain-and HD domain-containing protein 1 (SAMHD1) is the first deoxynucleoside triphosphate triphosphohydrolase (dNTPase) identified in mammalian cells (Goldstone et al., 2011) . SAMHD1 induces the hydrolysis of dNTPs and, in concert with cellular ribonucleotide reductase, functions as a key regulator of intracellular dNTP homeostasis. In 2011, two laboratories independently identified SAMHD1 as a host restriction factor inhibiting human immunodeficiency virus type 1 (HIV-1) infection in non-dividing myeloid cells (Hrecka et al., 2011; Laguette et al., 2011) . The viral protein X (Vpx) uniquely expressed by lentiviruses such as HIV-2 and many strains of simian immunodeficiency virus, but not by HIV-1, has been shown to restore HIV-1 infection in myeloid cells (Guyader et al., 1989; Yu et al., 1991) . The underlying molecular mechanisms remained unknown until the discovery that Vpx targets SAMHD1 for proteasomal degradation, thus counteracting its restriction activity and supporting HIV-1 infection (Hrecka et al., 2011; Laguette et al., 2011) . We and others showed that SAMHD1 dNTPase activity is responsible for the extremely low dNTP concentrations associated with the kinetic delay in HIV-1 reverse transcription, and that Vpx accelerates the viral DNA synthesis by elevating cellular dNTP levels in myeloid cells and resting CD4 + T lymphocytes, thus revealing the mechanistic and regulatory links among SAMHD1, Vpx, cellular dNTPs, and viral reverse transcription kinetics (Baldauf et al., 2012; Kim et al., 2012; Lahouassa et al., 2012; St Gelais et al., 2012) . Besides its dNTP hydrolase function, SAMHD1 harbors RNase and nuclease activities, which have been postulated to possibly contribute to HIV-1 restriction (Beloglazova et al., 2013; Choi et al., 2015; Ryoo et al., 2014) , although these results require further validation.
In addition to the role of SAMHD1 as a host restriction factor, mutations in the SAMHD1 gene have been linked to a genetic immune disorder called Aicardi-Goutières Syndrome (AGS) (Rice et al., 2009) , as well as several types of cancer, of both solid and hematological origins [reviewed in (Kohnken et al., 2015) ]. These accumulating lines of evidence suggest the involvement of SAMHD1 in the innate immune response and cancer development through the control of dNTP homeostasis. In the last few years, intense efforts have been carried out in order to define the mechanisms by which SAMHD1 interferes with HIV-1 infection in non-dividing cells (Wu, 2013) , and unravel its role in immunological diseases and cancer development. However, the physiological functions of SAMHD1 remain to be fully defined, and elucidation of the underlying mechanisms would help the development of potential therapeutic approaches in the context of HIV-1, AGS and cancer.
Here, we developed a monocytic THP-1 cell line model presenting stable knockout (KO) of the SAMHD1 gene by using the CRISPR/Cas9 genome editing technology. We aimed to characterize the phenotype of THP-1 cells lacking SAMHD1 protein in comparison to control cells expressing the endogenous and functional protein. We focused on the effects of SAMHD1 on cell proliferation, cell cycle regulation and cell death, and their potential correlation with HIV-1 restriction. We found that SAMHD1 silencing leads to increased cell growth, perturbation of the cell cycle and reduced susceptibility to apoptosis. Moreover, we observed increased dNTP levels and enhanced HIV-1 infection in dividing SAMHD1 KO THP-1 cells relative to control cells, thus confirming the role of SAMHD1 in the control of HIV-1 life cycle in myeloid cells. Our results shed light on a functional interplay between SAMHD1-mediated regulation of cell cycle, apoptosis and HIV-1 infection through its dNTPase activity.
Results
Stable silencing of the SAMHD1 gene in THP-1 cells THP-1 cells have been widely used as a cell line model to investigate the functions of primary myeloid-lineage cells such as monocytes, macrophages and dendritic cells (Auwerx, 1991; Berges et al., 2005; Chanput et al., 2014) . Here, we employed the CRISPR/Cas9 technology to knockout SAMHD1 in THP-1 cells. We chose the THP-1 cell line for our model system because, opposed to other monocytic cell lines such as U937 cells lacking endogenous SAMHD1 expression, THP-1 cells express similar levels of SAMHD1 compared to primary myeloid cells (Laguette et al., 2011) . Two single guide RNAs (gRNA 1 and gRNA 2 indicated in Fig. 1A ) targeting unique sequences in exon 1 of the SAMHD1 gene were designed and cloned into a lentiviral vector Shalem et al., 2014) . Polyclonal undifferentiated THP-1 cells were transduced with a lentiviral vector expressing gRNA 1 or gRNA 2, Cas9 and a puromycin resistance marker . To assess the ability of the gRNAs to cleave SAMHD1, we used the Surveyor nuclease assay (Guschin et al., 2010; Ran et al., 2013) . Compared to untargeted cells, cleavage products were detected only in genomic DNA from polyclonal THP-1 cells transduced with lentiviral vector containing either gRNA 1 or 2 (Fig. 1B, shown by arrows), indicating that the gRNAs successfully targeted the region of interest and, therefore, are valid candidates for knocking out SAMHD1. Immunoblotting analysis confirmed the loss of SAMHD1 expression in three cell clones transduced with two different gRNAs targeting SAMHD1 (KO), while endogenous SAMHD1 expression was detected in the THP-1 clones transduced with the control vector ( Fig. 1C and Supplementary Fig. 1A ).
As SAMHD1 is a key regulator of intracellular dNTP homeostasis (Ballana and Este, 2015) , we analyzed dNTP levels in non-differentiated SAMHD1 KO and control cells by using our previously described dNTP assay (Diamond et al., 2004) . Intracellular dNTP pools increased 3-to 6-fold in SAMHD1 KO compared to control cells, as shown in Fig. 1D (KO clone 1, derived from gRNA 2, and control clone 1, referred respectively as KO and control from here on) and Supplementary Fig. 1B . Our data are consistent with previously published results showing a significant increase in the dNTP levels in primary human macrophages or dendritic cells in which efficient SAMHD1 degradation was induced by Vpx (Hollenbaugh et al., 2014b; Kim et al., 2012; St Gelais et al., 2012) , thus further confirming that the complete silencing of SAMHD1 expression in KO cells leads to up-regulation of the intracellular dNTP pool.
Silencing of SAMHD1 affects cell proliferation and alters cell cycle status
Overexpression of SAMHD1 has been described to reduce the proliferation of HeLa cells and the lung cancer cell line A549 (Clifford et al., 2014; Wang et al., 2014) . To investigate the effect of SAMHD1 on THP-1 cell growth, we analyzed the proliferation of nondifferentiated control and KO cells by trypan blue exclusion and 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) assays. By performing a time course experiment, we observed enhanced growth rate and viability of KO cells compared to control cells, with a significant increase of the number of live cells at days 5 and 7 after seeding (1.6 and 1.4-fold, respectively, Fig. 2A ), while a significant increase of cell proliferation and metabolism (1.3-fold) was observed from day 3 to day 7 (Fig. 2B) . These results prompted us to investigate whether SAMHD1 may induce perturbation of the cell cycle. Flow cytometry analysis performed in asynchronous cells over a period of 7 days showed that knockout of SAMHD1 was associated with significantly increased G 1 /G 0 cell population in comparison to control cells, while a decrease was observed in the fraction of cells in G 2 /M phase (Fig. 2C) . A similar cell cycle profile was obtained in cells synchronized in G 1 phase by serum starvation (data not shown), further suggesting that SAMHD1 delays cell cycle progression most likely through accumulation of the cells in G 2 /M. Notably, additional two SAMHD1 KO cell clones (derived from gRNA 1 or 2) showed similar phenotypes compared to control cells ( Supplementary Fig. 1C-D) , thus confirming that the effects on cell proliferation and cell cycle status can be specifically ascribed to SAMHD1 silencing. Although the investigation of the molecular mechanisms associated with these effects is beyond the scope of this study, these data suggest that SAMHD1 negatively impacts cell cycle progression, leading to reduced cell growth and proliferation.
Silencing of SAMHD1 results in reduced spontaneous activation of apoptosis
We next evaluated whether reduced proliferation of control cells is correlated with increased cell death. We analyzed apoptosis induction by Annexin-V staining, which allowed us to distinguish cells in early and late apoptosis due to the exposure of phosphatidylserine residues on the cell membrane, an event occurring at early stages during apoptotic cell death (Verhoven et al., 1995) . As shown in Fig. 3A and Supplementary Fig. 2A , a higher percentage of early or late apoptotic cells was observed, respectively, at 1 or 3 days postseeding in SAMHD1 expressing control cells compared to KO cells, consistently with more pronounced cell proliferation ( Fig. 2B and Supplementary Fig. 1C ) and G 1 /G 0 accumulation ( Fig. 2C and Supplementary Fig. 1D ) detected in KO clones. In line with the data in Fig. 2A showing more robust cell viability, flow cytometry analysis of apoptosis demonstrated a higher percentage of the live KO cell population compared to control cells (Fig. 3A , left panel). Moreover, cells expressing SAMHD1 showed increased activation of caspase 3, as demonstrated by detection of cleaved active forms of caspase 3 and cleavage of poly (ADPribose) polymerase (PARP), a known target of active caspase 3 and marker of apoptosis (Boulares et al., 1999) (Fig. 3B and Supplementary Fig. 2B ), and by direct measurement of caspase 3/7 activities using a luminescence-based assay ( Fig. 3C and Supplementary Fig.  2C ). Compared to control cells, SAMHD1 KO cells showed very low or absent caspase activation (e.g., 7-fold decrease at day 3 in Fig. 3C ). These data suggest that SAMHD1 silencing may render the cells less prone to apoptosis compared to normal cells.
Effect of SAMHD1 knockout and overexpression on HIV-1 infection in THP-1 cells
SAMHD1 is a known restriction factor of HIV-1 infection in non-dividing cells such as primary monocytes, dendritic cells, macrophages and resting CD4 + T-cells, where SAMHD1 is highly expressed (Baldauf et al., 2012; Berger et al., 2012; Hrecka et al., 2011; Laguette et al., 2011) . SAMHD1-mediated HIV-1 restriction in phorbol 12-myristate 13-acetate (PMA)-differentiated, non-dividing macrophage-like cells (such as THP-1 or U937 cell lines) has been previously reported (Laguette et al., 2011; Lahouassa et al., 2012) , but its effect on virus infection efficiency in dividing monocytic cell lines has not been carefully characterized. To explore this aspect and identify a potential link between SAMHD1 restriction activity and its effects on cell proliferation, cell cycle and apoptosis, we first analyzed SAMHD1 expression in control and KO cells differentiated or not with PMA treatment. Immunoblotting analysis showed a modest increase of SAMHD1 protein level in PMA-differentiated non-cycling control cells, in line with our published results (St Gelais et al., 2014) (Fig. 4A) . Next, non-differentiated and differentiated THP-1 control and SAMHD1 KO cells were infected with a single-cycle luciferase reporter HIV-1 pseudotyped with the vesicular stomatitis virus protein G (HIV-1-Luc/VSV-G) (Wang et al., 2016) . Luciferase activity was measured at 24 and 48 hours post-infection (hpi) as an indication of infection efficiency. At 24 hpi, cycling KO cells were more susceptible to HIV-1 infection compared to control cells (5-fold increase, Fig. 4B left panel) , indicating that SAMHD1 is able to counteract HIV-1 infection in dividing THP-1 monocytic cells. At 48 hpi, HIV-1 infection efficiency was similar in the two cell lines, irrespective of SAMHD1 expression. Further investigation is required to unravel the mechanism responsible for the loss of SAMHD1 restriction activity in these cells at this time point. Conversely, in non-cycling SAMHD1 KO cells, HIV-1 infection was more efficient at both time points (14-and 20-fold increase at 24 and 48 hpi, respectively) (Fig. 4B, right panel) , confirming that silencing of SAMHD1 in THP-1 cells results in the expected HIV-1 restriction phenotype as described in published studies (Laguette et al., 2011; Lahouassa et al., 2012; St Gelais et al., 2014) .
To confirm that the effects on dNTP intracellular concentration (Fig. 1D ) and HIV-1 infection (Fig. 4B ) observed in KO cells were due to the absence of SAMHD1 expression, the mutated SAMHD1 gene resistant to the CRISPR/Cas9 targeting was re-introduced into the KO cells by transducing the KO cell line derived from gRNA 2 with either control vector (Lvx) or SAMHD1-expressing (SAM) lentiviruses. The clones (six for Lvx and four for the SAMHD1 expression vector) were analyzed for SAMHD1 expression after differentiation with PMA (Fig. 4C ). As expected, SAMHD1 protein was not detected in the six Lvx clones, whereas four SAM clones displayed robust SAMHD1 expression. Notably, SAMHD1 expression levels in the SAM clones were significantly higher than those in THP-1 parental and control cells (Fig. 4C and data not shown). Overexpression of SAMHD1 reversed the increased dNTP concentration phenotype observed in the KO and Lvx cells (Fig. 4D) . Interestingly, dATP, dGTP and dTTP levels in the SAMHD1 cells were lower than those detected in control cells (Fig. 4D ). This could be due to the increased expression of SAMHD1 in the SAM clones compared to the control cells.
Furthermore, we investigated the effect of SAMHD1 overexpression on HIV-1 infection of differentiated cells. PMA-treated THP-1 cells were infected with VSV-G-pseudotyped HIV-1-GFP (Diamond et al., 2004) and analyzed for GFP expression by flow cytometry at 72 hpi. As shown in Fig. 4E , KO and Lvx THP-1 cells lacking SAMHD1 displayed elevated HIV-1 infection compared to control cells (7-and 5-fold increase, respectively), correlating the loss of SAMHD1 with enhanced HIV-1 replication. HIV-1 infection was limited in SAM cells, which were also more effective at HIV-1 restriction than the control cells (Fig. 4E) , consistently with the higher SAMHD1 expression and lower dNTP concentration observed in the SAM cells ( Fig. 4C and 4D ). These data indicate the tight interplay among SAMHD1 expression levels, dNTP concentrations, and HIV-1 infection efficiency, which we and others have previously observed in primary human macrophages or dendritic cells (Baldauf et al., 2012; Kim et al., 2012; Laguette et al., 2011; Lahouassa et al., 2012; St Gelais et al., 2012) . Lastly, we sought to test whether the SAM clones were sensitive to Vpx-mediated SAMHD1 degradation and the treatment with deoxynucleosides (dNs), which independently elevate intracellular dNTP levels through the salvage pathway of dNTP synthesis (Lahouassa et al., 2012) . We used a combined Vpx/dNs treatment as neither treatment alone resulted in a significant increase of HIV-1 infection efficiency (data not shown), most likely due to the very high expression levels of SAMHD1 in the SAM clones. As expected, SAMHD1-mediated suppression of HIV-1 infection of SAM cells was rescued by the combined Vpx/dNs treatment (Fig. 4E) .
Taken together, these results show that SAMHD1 knockout and overexpression in THP-1 cells modulate HIV-1 infection by regulating the intracellular dNTP concentration, thus biochemically and virologically mimicking what is observed with primary monocyte-derived macrophages or dendritic cells, and can be a convenient tool to further study the precise mechanisms of SAMHD1-mediated retroviral restriction.
Discussion
SAMHD1 is a cellular restriction factor that limits HIV-1 infection in non-dividing myeloid cells and resting CD4 + T cells, by inducing the hydrolysis of dNTPs, which inhibits the viral reverse transcription process (Baldauf et al., 2012; Lahouassa et al., 2012) . Non-productive infection of myeloid cells by SAMHD1 likely prevents activation of anti-viral immune responses, which may allow HIV-1 to escape immune recognition and establish persistent infection (Wu, 2012) . Therefore, complete elucidation of the physiological functions of SAMHD1 in myeloid cells is important for the development of potential anti-viral approaches.
In this study, we generated a stable SAMHD1 KO THP-1 cell line to explore the effect of silencing SAMHD1 on cell proliferation, cell-cycle progression, and apoptosis. Beside its role in HIV-1 restriction, SAMHD1 is known to influence the proliferation of several cell types by regulating dNTP homeostasis (Kohnken et al., 2015) . We characterized the phenotype of dividing SAMHD1 KO THP-1 cells in comparison to control cells, and found that SAMHD1 reduces cell proliferation and metabolism, in line with previous published work showing that overexpression of SAMHD1 negatively affects the proliferation of cancer cells (Clifford et al., 2014; Wang et al., 2014) . Moreover, we observed that silencing of SAMHD1 redistributes cells mainly in the G 1 /G 0 phase of the cell cycle. Our results are consistent with published data showing that SAMHD1 knock-down in proliferating human fibroblast cell lines (Franzolin et al., 2013) and that SAMHD1 mutations in fibroblasts from AGS patients (Kretschmer et al., 2015) result in accumulation of the cells in G 1 , decreased percentage of cells in G 2 and increase of the intracellular dNTP pools. In addition to its effect on cell cycle progression, we found that SAMHD1 regulates apoptosis. Indeed, KO cells appear to be more resistant to spontaneous apoptotic cell death relative to control cells, as demonstrated by the reduced activation of caspase 3/7 and absent cleavage of the apoptotic marker PARP. Importantly, the effects of SAMHD1 silencing on cell growth, proliferation, cell cycle progression and apoptosis induction were observed in an additional control and two KO clones, thus suggesting that the phenotype described is unlikely due to off-target effects of the CRISPR/Cas9 system, and further confirming a key role of SAMHD1 in these processes.
Notably, changes in cell cycle progression were consistently associated with altered expression of cyclin D3. Our unpublished results revealed that the cyclin D3 mRNA level is significantly down-regulated in KO cells compared to control cells (data not shown). This data is consistent with accumulation of SAMHD1 KO cells in G 1 /G 0 , as cyclin D3 controls cell cycle progression at G 1 /S phase (Bartkova et al., 1998; Herzinger and Reed, 1998) . Further investigation will help elucidate a potential interplay of cyclin D3 with SAMHD1-mediated control of cell proliferation.
We found that disturbances in cell cycle progression induced by SAMHD1 silencing are associated with increased intracellular dNTP concentrations and more productive HIV-1 infection of KO versus control cells. Previous studies from our and other groups showed that overexpressed SAMHD1 does not restrict HIV-1 infection in dividing HeLa and HEK293T cells (St Gelais et al., 2012; St Gelais et al., 2014; Welbourn and Strebel, 2016 ). Here we provide first evidence that SAMHD1 limits HIV-1 infection in actively proliferating THP-1 cells, and that the absence of SAMHD1 renders the cells more susceptible to HIV-1 infection. Increased HIV-1 infection efficiency could also be detected in differentiated cells, thus confirming the established HIV-1 restriction ability of SAMHD1 in non-dividing cells (Lahouassa et al., 2012) , and further validating our THP-1 SAMHD1 KO model as a useful tool to study SAMHD1 functions in monocytic cells. Of note, while the enhancement of HIV-1 infection in differentiated KO cells is detected at both time points tested (24 and 48 hpi), we observed similar viral infection efficiency in non-differentiated control and SAMHD1 KO cells at 48 hpi. We exclude the possibility that this effect could be due to increased SAMHD1 T592 phosphorylation status, which is known to negatively regulate its HIV-1 restriction activity (Cribier et al., 2013; White et al., 2013) , at 48 hpi (data not shown). Further analysis is needed to identify the responsible mechanisms. Importantly, by performing SAMHD1 knock-in experiments, we could reverse the phenotype observed in KO cells, confirming that the increase in dNTP levels and HIV-1 infection efficiency was mainly due to the absence of SAMHD1. Moreover, in cells overexpressing SAMHD1, its expression or activity could be impaired by co-treatment with Vpx and dNs, which are known to counteract SAMHD1-mediated HIV-1 restriction (Laguette et al., 2011; Lahouassa et al., 2012) . Of note, SAMHD1 overexpressing cells showed even lower dNTP concentrations and more efficient HIV-1 restriction compared to control cells, which could be due to different expression levels of SAMHD1 protein in the two cell lines.
Correlation between cell cycle progression and SAMHD1 expression levels and its HIV restriction function remains to be confirmed (Franzolin et al., 2013; Kretschmer et al., 2015; Pauls et al., 2014; Yan et al., 2015) . A complete picture of the mechanisms by which SAMHD1 influences cell cycle regulation is still missing, and it would be interesting to further investigate how cell cycle regulation affects its HIV-1 restriction activity in dividing cells, as well as to identify the role of cell cycle-related proteins during retroviral infection in myeloid cells.
In summary, by using a novel THP-1-derived cell model, we suggest that SAMHD1 can act as a regulator of the cell cycle and apoptosis-inducing factor in cycling THP-1 monocytic cells. These effects correlated with HIV-1 restriction, thus proposing a functional link between cell cycle control and HIV-1 restriction by SAMHD1. The new THP-1 cell model that we generated can expedite preliminary in vitro studies and future in vivo translational investigations, thus helping elucidate the cellular functions of SAMHD1 and mechanisms of retroviral restriction.
Materials and methods

Generation of SAMHD1 knockout THP-1 cells
Two single guide RNAs (gRNAs) targeting unique sequences of the SAMHD1 gene were designed and cloned into the lentiCRISPR v1 plasmid, which contains a puromycin resistance cassette and Cas9 nuclease Shalem et al., 2014) . Lentiviral vectors were produced by co-transfection of polyclonal THP-1 cells with the lentiCRISPR v1/gRNA, d8.74 and pMD2 plasmids using the cationic polymer polyethylenimine (PEI) method (Boussif et al., 1995) . Viral supernatant was collected and used to transduce polyclonal undifferentiated THP-1 cells. Both gRNA constructs were functionally tested for their ability to mediate genomic insertion, deletion or inversions by isolating the genomic DNA from stably transduced and selected polyclonal population of THP-1 cells and performing a Surveyor nuclease assay as per manufacturer's instructions (Guschin et al., 2010; Ran et al., 2013) . Puromycin resistant cells were selected from each gRNA vector transduction, and then sorted by fluorescence-activated cell sorting (FACS) into 96-well plates for clonal expansion.
Generation of SAMHD1 overexpressing cell line
Silent mutations in the SAMHD1 gene were introduced by site directed mutagenesis (QuikChange Lightning kit, Agilent Genomics) to make it resistant to the gRNA 2-mediated CRISPR/Cas9 cleavage. The following primers were used: 5′-GAAGCTGATTGGTCACCTGGACTAGAACTCCATCCCGACTAC-3′ and 5′-GTAGTCGGGATGGAGTTCTAGTCCAGGTGACCAATCAGCTTC-3′. This Cas9 resistant SAMHD1 gene was cloned into LVX-IRES-mCherry vector (Clontech). Lentiviral vectors containing either LVX-IRES-mCherry control (Lvx, expressing only mCherry) or LVX-SAMHD1-IRES-mCherry (SAM, expressing SAMHD1 and mCherry) were produced by cotransfection of HEK293FT cells using the PEI method (Boussif et al., 1995) . Viral supernatant was used to transduce the gRNA 2 KO cells. The mCherry expressing THP-1 cells were single-cell sorted by FACS into 96-well plates and clonally expanded.
Cell culture
THP-1-derived control, SAMHD1 KO, Lvx and SAM cell clones were maintained in RPMI-1640 (ATCC), supplemented with 10% fetal bovine serum, 100 U/ml penicillin, 100 μg/ml streptomycin and 1 μg/ml puromycin at 37°C, 5% CO 2 . To induce differentiation into non-dividing, macrophage-like cells, cells were treated with 100 ng/ml PMA for 24 or 72 hours. HEK293FT cells were grown in DMEM containing 10% fetal bovine serum, 100 U/ml penicillin, 100 μg/ml streptomycin. GHOST/X4/R5 cells used for virus titration purposes were cultured as described (Wang et al., 2016) .
Live cell counting
Control or SAMHD1 KO THP-1 cells (2.5×10 4 cells per well) were seeded in four replicates in 96-well plate in 100 μl of culture media. At the indicated time points, trypan blue was added to each well and live cell numbers were counted.
MTS assay for cell proliferation
Cell proliferation was measured according to the colorimetric CellTiter 96 ® AQueous One Solution Cell Proliferation Assay (Promega). Control or SAMHD1 KO THP-1 cells (2.5×10 4 cells per well) were seeded in four replicates in 96-well plate in 100 μl of culture media. Wells containing only media were used for background measurement. At the indicated time points, plates were incubated for 1 hour at 37ºC with 20 μl of MTS reagent and absorbance at 490 and 690 nm (specific and non-specific readings, respectively) was read with a plate reader. Cell proliferation was calculated as the average of 490 nm absorbance values, corrected for non-specific and background readings, of four replicates per sample.
Cell cycle analysis by propidium iodide staining
Control and SAMHD1 KO THP-1 cells were seeded, in triplicate, in 12-well plates at a density of 2×10 5 cells per well. At day 0, 1, 3, 5 and 7 after seeding, cells were counted, harvested, fixed in 70% ice-cold ethanol, and stained with Guava Cell Cycle Reagent (EMD Millipore), according to the manufacturer's instructions. Cell cycle data was then acquired on the Guava flow cytometer instrument and analyzed using Cytosoft 4.2.
Detection of apoptosis by Annexin-V staining
Control and SAMHD1 KO THP-1 cells were seeded as described for the cell cycle analysis. At day 0, 1, 3, 5 and 7 after seeding, cells were counted, washed in ice-cold PBS and resuspended in 1X Binding Buffer at a concentration of 1×10 6 cells/ml. Cells were then stained with PE-Annexin V and 7-Amino-Actinomycin (7-AAD) using the PE Annexin V Apoptosis Detection Kit I (BD Pharmingen), according to the manufacturer's instructions. Apoptosis data was acquired on the Guava flow cytometer, data analysis and gating was performed using FlowJo software.
Caspase 3/7 activation assay
Control and SAMHD1 KO THP-1 cells (5×10 5 per well) were seeded in 6-well plates. At day 0, 1, 3, 5 and 7 after seeding, cells were counted and 1×10 4 cells per well were transferred into a 96-well plate. Caspase 3/7 activity was determined using the luminescent Caspase-Glo 3/7 assay kit (Promega), according to manufacturer's instructions. Briefly, plates were incubated for 1 hour at room temperature with 100 μl/well of Caspase-Glo 3/7 reagent, and luciferase activity was measured with a plate reader (Perkin Elmer). Wells containing only cell culture media were used to measure background luminescence, which was subtracted from experimental values.
Immunoblotting analysis
Cells were harvested, washed with PBS and lysed in cell lysis buffer (Cell Signaling) containing protease inhibitor (Sigma-Aldrich) as described (Wang et al., 2016) . Cell extracts were resolved by SDS-PAGE and subjected to immunoblotting analysis using the following antibodies: rabbit polyclonal anti-SAMHD1 antibody (ProSci, #1224), rabbit polyclonal anti-caspase 3 antibody (Cell Signaling, #9662S), rabbit polyclonal anti-PARP antibody (Cell Signaling, #9542). Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) detection (AbD serotec) was used as loading control. Immunoblotting images were captured and analyzed by the Luminescent Image analyzer (LAS 4000) as previously described (Wang et al., 2016) .
HIV-1 production and infection assays
Single cycle, luciferase reporter HIV-1-Luc/VSV-G was produced and titrated as previously described (Wang et al., 2016) . Control or SAMHD1 KO THP-1 cell lines were infected with HIV-1-Luc/VSV-G at a multiplicity of infection (MOI) of 1 infectious unit per cell and infection efficiency was determined by measuring luciferase activity at 24 and 48 hpi using a luciferase reporter kit (Promega), according to manufacturer's instructions. Luciferase values were normalized to total protein concentration determined by bicinchoninic acid assay (BCA, Pierce). VSV-G pseudotyped D3HIV-GFP virus was produced as previously described with slight modification (Diamond et al., 2004) . Briefly, HEK293FT cells were co-transfected with VSV-G protein and D3HIV-GFP, in which env and nef genes are deleted and replaced with GFP. Viral supernatant was collected at 48 hpi and concentrated (~200-fold) by ultracentrifugation at 22,000 rpm for 2 hours at 4°C. All PMA-differentiated THP-1 cells were infected with equal amounts of D3 vector by spinfection at 400 g for 30 min. Cells were analyzed for GFP expression 72 hpi by flow cytometry (Miltenyi MACSQuant).
Intracellular dNTP measurement
Cellular dNTP levels were determined by a single nucleotide RT incorporation assay as previously described (Diamond et al., 2004) . Four distinct 19-mer DNA templates, each with a distinct nucleotide (N) at the 5′ end (5′-NTGGCGCCCGAACAGGGAC-3′), were separately annealed to an 18-mer primer (5′-GTCCCTGTTCGGGCGCCA-3), 32P-labelled at its 5′ end. Reactions contained 200 fmol template/primer, 4 μL of purified RT (HIV-1 HXB2), 25 mM Tris-HCl, pH 8.0, 2 mM dithiothreitol, 100 mM KCl, 5 mM MgCl2, and 10 μM oligo(dT), and cellular dNTP extracts (diluted to be within linear range of the assay, 2-50%) in a final volume of 20 μL/reaction. Reactions were incubated at 37°C for 5 min and then quenched with 10 μL of 40 mM EDTA and 99% (vol/vol) formamide at 95°C for 2 min. The reactions were resolved on a 14% urea-PAGE gel (AmericanBio, Inc.) and analyzed using Pharos FX molecular imager (Biorad). The images were analyzed using ImageLab software.
Vpx and dNs treatment
Virus-like particles containing Vpx were generated as previously described (Hollenbaugh et al., 2014a) . PMA differentiated THP-1 were transduced with Vpx containing VLPs 18 hours prior to infection with HIV-1 GFP. At 4 hours prior to infection, cells were also treated with 2.5 mM dNs. Cells were subsequently washed with PBS twice and infected as described above.
Statistical analysis
Data were analyzed using the Student T test or Two-way ANOVA followed with Bonferroni test in Graphpad 5.0. Statistical significance was defined at P <0.05.
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Refer to Web version on PubMed Central for supplementary material. expressing HIV-1 virus and, after 72 hours, the percentage of GFP-positive cells was measured by flow cytometry. While silencing of SAMHD1 results in more efficient HIV-1 infection, overexpression of SAMHD1 in KO cells restores SAMHD1 restriction effects. Counteraction of SAMHD1-mediated viral restriction was detected in SAM cells co-treated with Vpx and dNs.
